Feng Shu-Yu, Zhang Yan-Na, Liu Jian-Gang
Key Laboratory of Oncology in Southern China, Guangzhou, Guangdong, P. R. China.
Ai Zheng. 2005 Oct;24(10):1261-6.
BACKGROUND & OBJECTIVE: Pelvic lymph node metastasis is an important prognostic factor of cervical carcinoma, but few have been reported on both risk factors and prognostic factors of node-positive cervical carcinoma. This study was to evaluate risk factors, distribution pattern, and prognosis of node-positive cervical carcinoma, and explore the forecast of lymph node metastasis and appropriate treatment.
Clinical data of 205 cervical cancer patients who had undergone radical hysterectomy and bilateral pelvic lymphadenectomy were analyzed retrospectively.
The overall prevalence of lymph node metastasis was 24.4% (50/205). Univariate analysis showed that risk factors of node metastasis were serum level of squamous cell carcinoma antigen (SCC-Ag) before treatment, clinical stage, invasive depth of cervical canal or vaginal portion of the cervix, and uterine ligaments involvement. SCC values exceeding 4 microg/L increased the risk of nodal metastasis by 4.2 folds (P<0.001, OR=4.212). Multivariate analysis showed that clinical stage and invasive depth of cervical canal were the major risk factors. The obturator and obturator fossae lymph nodes were the most frequently involved, with a rate of 48.0%. Moreover, 60.0% node-positive patients had multiple sites lymph node metastases, and saltatory metastasis was found. Lymph node metastasis was closely related to deep muscularis involvement of the cervix and parametrial involvement; 72.0% nodal metastases were accompanied with deep muscularis involvement of the cervix, 90.9% uterine ligament invasions were accompanied with lymph node metastasis. The 5-year survival rate was significantly higher in the patients received postoperative radiation than in the patients didn't receive radiation (89.1% vs. 45.5%, P=0.012).
Serum level of SCC-Ag before treatment exceeding 4 microg/L, deep muscularis involvement of vaginal portion of the cervix, uterine ligaments involvement, especially advanced stage and deep muscularis involvement of the cervical canal, are risk factors of pelvic lymph node metastasis of cervical cancer. The standard type III radical hysterectomy and bilateral pelvic lymphadenectomy should be performed to the patients with high risk of lymph node metastasis to ensure enough amplitude of parametrectomy and excision of positive nodes. When lymph node metastasis is confirmed after surgery, postoperative radiation can improve the prognosis.
盆腔淋巴结转移是宫颈癌重要的预后因素,但关于淋巴结阳性宫颈癌的危险因素及预后因素的报道较少。本研究旨在评估淋巴结阳性宫颈癌的危险因素、分布模式及预后,并探讨淋巴结转移的预测及合适的治疗方法。
回顾性分析205例行根治性子宫切除术及双侧盆腔淋巴结清扫术的宫颈癌患者的临床资料。
淋巴结转移的总体发生率为24.4%(50/205)。单因素分析显示,淋巴结转移的危险因素为治疗前血清鳞状细胞癌抗原(SCC-Ag)水平、临床分期、宫颈管或宫颈阴道部的浸润深度以及子宫韧带受累情况。SCC值超过4μg/L使淋巴结转移风险增加4.2倍(P<0.001,OR=4.212)。多因素分析显示,临床分期和宫颈管浸润深度是主要危险因素。闭孔及闭孔窝淋巴结受累最为常见,发生率为48.0%。此外,60.0%的淋巴结阳性患者有多处淋巴结转移,并发现有跳跃性转移。淋巴结转移与宫颈深层肌层受累及宫旁组织受累密切相关;72.0%的淋巴结转移伴有宫颈深层肌层受累,90.9%的子宫韧带侵犯伴有淋巴结转移。接受术后放疗患者的5年生存率显著高于未接受放疗的患者(89.1%对45.5%,P=0.012)。
治疗前血清SCC-Ag水平超过4μg/L、宫颈阴道部深层肌层受累、子宫韧带受累,尤其是晚期及宫颈管深层肌层受累,是宫颈癌盆腔淋巴结转移的危险因素。对于淋巴结转移高危患者应行标准的III型根治性子宫切除术及双侧盆腔淋巴结清扫术,以确保足够的宫旁组织切除范围及阳性淋巴结切除。术后确诊有淋巴结转移时,术后放疗可改善预后。